Bindinglaw

US · guidance

CMS Pub. 100-03, ch. 1, § 30.8

Cellular Therapy

activein force · 2026-08-25 – presentas-observed

CIM 35-5

Not Covered

Cellular therapy involves the practice of injecting humans with foreign proteins like the

placenta or lungs of unborn lambs. Cellular therapy is without scientific or statistical

evidence to document its therapeutic efficacy and, in fact, is considered a potentially

dangerous practice. Accordingly, cellular therapy is not considered reasonable and

necessary within the meaning of §1862 (a) (1) of the Act.

History

(Rev. 1, 10-03-03)

Provenance

Source
cms.gov
Retrieved
2026-08-25
Edition
iom-2026-08-25
Content hash
5e2e3c4acc49fb4abef94712caaa9ecc625d9d043d18c01f6079f354a1fcafca
View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs

Bindinglaw

Point-in-time US law with the receipt attached. Source URL, retrieval time, content hash, and validity dates on every answer.

curl api.binding.law/v1/law/coverage

© 2026 binding.law · a Jubal, Inc. productAttorneys and firms never pay. Ever.